S-Biomedic NV

S-Biomedic NV is a Belgium-based life-science company founded in 2014, focusing on the skin microbiome to develop treatments and active ingredients for various skin disorders, including acne, eczema, and psoriasis. The company was co-founded by scientists Bernhard Paetzold and Marc Güell, who adapted gut microbiome transplantation techniques for skin applications. CEO Veronika Oudova leads the commercialization efforts, aiming to establish S-Biomedic as a global leader in microbiome-based dermatological solutions.

The company offers living skin probiotics derived from Cutibacterium, designed to modulate the skin microbiome and restore balance. Key products include the Sencyr® microbiome care program for acne-prone skin and a range of active ingredients targeting skin aging, dandruff, and more. S-Biomedic also provides contract manufacturing services for skincare products. With a strategic partnership with Beiersdorf AG, the company is advancing innovations in acne treatments and microbiome research.